Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (451-460 of 930) with videos related to

Pageof 93
Sort By:
Ejhaem|August 9, 2022
Severe aplastic anaemia after serial vaccinations for SARS-CoV-2, pneumococcus and seasonal influenzaXiao Wang, Dorottya Laczko, Gabriel C Caponetti, et al.
Ejhaem|August 5, 2021
Patterns of healthcare utilization among patients with sickle cell disease hospitalized with pain crisesAngie Mae Rodday, Kimberly S Esham, Nicole Savidge, et al.
Ejhaem|September 2, 2022
Frontline polatuzumab vedotin for diffuse large B-cell lymphoma: A survey of clinician impressionsAjay Major, Edward R Scheffer Cliff, Daniel A Ermann, et al.
Ejhaem|September 2, 2022
Acquired factor VII inhibitor associated with primary central nervous system Lymphoma: A case reportVanshika Goyal, Giselle Salmasi, Andrew D Leavitt, et al.
Ejhaem|September 2, 2022
Point of care testing to monitor INR control in patients with antiphospholipid syndromeMichael Masucci, Annabelle Li Kam Wa, Emilia Shingleton, et al.
Ejhaem|September 2, 2022
Long-term observation of the frequency of secondary colorectal cancer and other malignancies in tyrosine kinase inhibitor treated chronic myeloid leukemia patients and controlsNina Winkelmann, Michaela Schwarz, Bert Hildebrandt, et al.
Ejhaem|September 2, 2022
Longitudinal trends of peripheral blood counts in polycythaemia vera and essential thrombocythemia patients in the UKLewis Carpenter, Patrick Rockenschaub, Grace B Hatton, et al.
Ejhaem|September 2, 2022
Unusually swift response of relapsed Burkitt leukemia to R-DHAPDennis Christoph Harrer, Alexander Denk, Felix Keil, et al.
Ejhaem|September 2, 2022
Long-term efficacy and safety of programmed death-1 (PD-1) antibody alone in relapsed/refractory human immunodeficiency virus-associated Hodgkin lymphomaChaoyu Wang, Fanlin Zhou, Lingqian Zhang, et al.
Ejhaem|December 15, 2021
Using lysis therapy to treat five critically ill COVID-19 patients who show echocardiographic criteria of right ventricular strainAhmed Mahdy, Eslam Abbas, Rawad Tarek, et al.
Pageof 93

Showing results (451-460 of 930) with videos related to

Sort By:
Pageof 93
Ejhaem|August 9, 2022
Severe aplastic anaemia after serial vaccinations for SARS-CoV-2, pneumococcus and seasonal influenzaXiao Wang, Dorottya Laczko, Gabriel C Caponetti, et al.
Ejhaem|August 5, 2021
Patterns of healthcare utilization among patients with sickle cell disease hospitalized with pain crisesAngie Mae Rodday, Kimberly S Esham, Nicole Savidge, et al.
Ejhaem|September 2, 2022
Frontline polatuzumab vedotin for diffuse large B-cell lymphoma: A survey of clinician impressionsAjay Major, Edward R Scheffer Cliff, Daniel A Ermann, et al.
Ejhaem|September 2, 2022
Acquired factor VII inhibitor associated with primary central nervous system Lymphoma: A case reportVanshika Goyal, Giselle Salmasi, Andrew D Leavitt, et al.
Ejhaem|September 2, 2022
Point of care testing to monitor INR control in patients with antiphospholipid syndromeMichael Masucci, Annabelle Li Kam Wa, Emilia Shingleton, et al.
Ejhaem|September 2, 2022
Long-term observation of the frequency of secondary colorectal cancer and other malignancies in tyrosine kinase inhibitor treated chronic myeloid leukemia patients and controlsNina Winkelmann, Michaela Schwarz, Bert Hildebrandt, et al.
Ejhaem|September 2, 2022
Longitudinal trends of peripheral blood counts in polycythaemia vera and essential thrombocythemia patients in the UKLewis Carpenter, Patrick Rockenschaub, Grace B Hatton, et al.
Ejhaem|September 2, 2022
Unusually swift response of relapsed Burkitt leukemia to R-DHAPDennis Christoph Harrer, Alexander Denk, Felix Keil, et al.
Ejhaem|September 2, 2022
Long-term efficacy and safety of programmed death-1 (PD-1) antibody alone in relapsed/refractory human immunodeficiency virus-associated Hodgkin lymphomaChaoyu Wang, Fanlin Zhou, Lingqian Zhang, et al.
Ejhaem|December 15, 2021
Using lysis therapy to treat five critically ill COVID-19 patients who show echocardiographic criteria of right ventricular strainAhmed Mahdy, Eslam Abbas, Rawad Tarek, et al.
Pageof 93